| A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis CH Polman, PW O'Connor, E Havrdova, M Hutchinson, L Kappos, ... New England Journal of Medicine 354 (9), 899-910, 2006 | 4126 | 2006 |
| Updated research nosology for HIV-associated neurocognitive disorders A Antinori, G Arendt, JT Becker, BJ Brew, DA Byrd, M Cherner, DB Clifford, ... Neurology 69 (18), 1789-1799, 2007 | 3155 | 2007 |
| HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study RK Heaton, DB Clifford, DR Franklin Jr, SP Woods, C Ake, F Vaida, ... Neurology 75 (23), 2087-2096, 2010 | 2739 | 2010 |
| HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors RK Heaton, DR Franklin, RJ Ellis, JA McCutchan, SL Letendre, S LeBlanc, ... Journal of neurovirology 17, 3-16, 2011 | 1830 | 2011 |
| Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system S Letendre, J Marquie-Beck, E Capparelli, B Best, D Clifford, AC Collier, ... Archives of neurology 65 (1), 65-70, 2008 | 1025 | 2008 |
| Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy TA Yousry, EO Major, C Ryschkewitsch, G Fahle, S Fischer, J Hou, ... New England Journal of Medicine 354 (9), 924-933, 2006 | 966 | 2006 |
| Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study DW Haas, HJ Ribaudo, RB Kim, C Tierney, GR Wilkinson, RM Gulick, ... Aids 18 (18), 2391-2400, 2004 | 802 | 2004 |
| Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases DB Clifford, A DeLuca, DM Simpson, G Arendt, G Giovannoni, A Nath The Lancet Neurology 9 (4), 438-446, 2010 | 755 | 2010 |
| PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section JR Berger, AJ Aksamit, DB Clifford, L Davis, IJ Koralnik, JJ Sejvar, R Bartt, ... Neurology 80 (15), 1430-1438, 2013 | 748 | 2013 |
| HIV-associated neurocognitive disorder DB Clifford, BM Ances The Lancet infectious diseases 13 (11), 976-986, 2013 | 747 | 2013 |
| HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group KP High, M Brennan-Ing, DB Clifford, MH Cohen, J Currier, SG Deeks, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 60, S1-S18, 2012 | 627 | 2012 |
| CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy RJ Ellis, J Badiee, F Vaida, S Letendre, RK Heaton, D Clifford, AC Collier, ... Aids 25 (14), 1747-1751, 2011 | 524 | 2011 |
| The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures DB Clifford, JW Olney, A Maniotis, RC Collins, CF Zorumski Neuroscience 23 (3), 953-968, 1987 | 474 | 1987 |
| Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study RK Heaton, DR Franklin Jr, R Deutsch, S Letendre, RJ Ellis, K Casaletto, ... Clinical Infectious Diseases 60 (3), 473-480, 2015 | 453 | 2015 |
| Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance CM Marra, Y Zhao, DB Clifford, S Letendre, S Evans, K Henry, RJ Ellis, ... Aids 23 (11), 1359-1366, 2009 | 444 | 2009 |
| Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 … PM Lantos, J Rumbaugh, LK Bockenstedt, YT Falck-Ytter, ... Clinical Infectious Diseases 72 (1), e1-e48, 2021 | 418 | 2021 |
| Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline I Grant, DR Franklin Jr, R Deutsch, SP Woods, F Vaida, RJ Ellis, ... Neurology 82 (23), 2055-2062, 2014 | 390 | 2014 |
| Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring L Kappos, D Bates, G Edan, M Eraksoy, A Garcia-Merino, N Grigoriadis, ... The Lancet Neurology 10 (8), 745-758, 2011 | 380 | 2011 |
| Continued high prevalence and adverse clinical impact of human immunodeficiency virus–associated sensory neuropathy in the era of combination antiretroviral therapy: the … RJ Ellis, D Rosario, DB Clifford, JC McArthur, D Simpson, T Alexander, ... Archives of neurology 67 (5), 552-558, 2010 | 377 | 2010 |
| Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection CD Hall, U Dafni, D Simpson, D Clifford, PE Wetherill, B Cohen, ... New England Journal of Medicine 338 (19), 1345-1351, 1998 | 358 | 1998 |
